Pay in 4 interest-free payments of $7.20 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Share your journey on your terms, not in response to other people's curiosity
In the SUSTAIN-7 randomized head-to-head trial, semaglutide demonstrated greater reductions in HbA1c and body weight compared with dulaglutide at comparable maintenance doses in patients with T2D inadequately controlled on metformin monotherapy [16]
Implications for employers: This study provides evidence that pharmaceutical manufacturers could make substantial profits selling these drugs at much lower costs in the US
metformin may be considered
US$ 27.55
US$ 29.16
US$ 23.94
US$ 26.21
US$ 28.66
